The rejuvenated pressurised metered dose inhaler
- 9 May 2007
- journal article
- review article
- Published by Informa Healthcare in Expert Opinion on Drug Delivery
- Vol. 4 (3), 215-234
- https://doi.org/10.1517/17425247.4.3.215
Abstract
The pressurised metered-dose inhaler (pMDI) has now been available for 50 years. Once regarded as an inefficient and difficult-to-use device, the technology has evolved significantly over the last few years, particularly since the introduction of novel formulations containing hydrofluoroalkane (HFA) propellants. Many modern HFA pMDIs deposit drug more efficiently in the lungs, impact less forcefully on the back of the throat and feel less cold than their chlorofluorocarbon pMDI counterparts. An improved understanding of technical factors makes it possible to design HFA pMDIs to have specific spray properties, particularly in terms of fine particle dose and spray velocity. Device technology has also progressed with the introduction of compact and convenient breath-actuated, breath-coordinated and velocity-modifying devices, which help patients to achieve a reliable lung dose. Although it faces competition from dry powder inhalers and possibly from novel soft-mist inhalers containing liquid formulations, the rejuvenated HFA pMDI is a device with a significant future for asthma, chronic obstructive pulmonary disease and wider treatment indications.Keywords
This publication has 85 references indexed in Scilit:
- Fluticasone propionate/salmeterol hydrofluoroalkane via metered-dose inhaler with integrated dose counter: performance and patient satisfactionInternational Journal of Clinical Practice, 2006
- Beclometasone Dipropionate/FormoterolDrugs, 2006
- Pharmacokinetic and Pharmacodynamic Properties of Inhaled Beclometasone Dipropionate Delivered Via Hydrofluoroalkane-Containing DevicesClinical Pharmacokinetics, 2005
- How Do Patients Determine That Their Metered-Dose Inhaler Is Empty?Chest, 2004
- Spacer Devices for Metered Dose InhalersClinical Pharmacokinetics, 2004
- Drug Delivery in Pediatric Patients with AsthmaAmerican Journal of Drug Delivery, 2003
- Medical aerosol propellantsJournal of Fluorine Chemistry, 2002
- The misconception of using floating patterns as an accurate means of measuring the contents of metered-dose inhaler devicesAnnals of Allergy, Asthma & Immunology, 2001
- Propellant-Driven Aerosols of ProteinsAerosol Science and Technology, 1996
- Pressurized aerosol inhaler technique: How important are inhalation from residual volume, inspiratory flow rate and the time interval between puffs?Respiratory Medicine, 1983